BlackRock Investment Management’s Cardiff Oncology CRDF Stock Holding History

BlackRock Investment Management’s Portfolio CRDF Stock Details CRDF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$237K	Hold	1,568	–	–	﹤0.01%	3209
2016 Q3	$507K	Sell	1,568 -5	-0.3%	-$1.82K	﹤0.01%	3038
2016 Q2	$513K	Buy	1,573 +83	+6%	+$28.6K	﹤0.01%	3055
2016 Q1	$499K	Buy	1,490 +32	+2%	+$10.9K	﹤0.01%	2905
2015 Q4	$567K	Buy	1,458 +20	+1%	+$7.83K	﹤0.01%	2954
2015 Q3	$589K	Buy	1,438 +237	+20%	+$124K	﹤0.01%	2952
2015 Q2	$877K	Buy	1,201 +1,144	+2,007%	+$811K	﹤0.01%	2869
2015 Q1	$28K	Buy	57 +13	+30%	+$5.55K	﹤0.01%	3378
2014 Q4	$14K	Hold	44	–	–	﹤0.01%	3548
2014 Q3	$15K	Hold	44	–	–	﹤0.01%	3504
2014 Q2	$11K	Buy	+44	New	+$14.1K	﹤0.01%	3593

Other funds holding CRDF

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PFS

Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

BlackRock Investment Management's CRDF Position: Q4 2016 in Review

BlackRock Investment Management held its Cardiff Oncology (CRDF) position steady in Q4 2016 at 1,568 shares worth $237K. The position accounts for ﹤0.01% of the portfolio, ranked #3209.

BlackRock Investment Management first reported a position in CRDF in Q2 2014 and has held it in 11 quarters since. The position peaked at $877K in Q2 2015. 68 funds tracked by Wall St. Rank hold CRDF as of Q4 2016.

BlackRock Investment Management held 1,568 shares of Cardiff Oncology worth $237K as of Q4 2016.
BlackRock Investment Management left its Cardiff Oncology share count unchanged in Q4 2016.
Cardiff Oncology made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3209 holding.
BlackRock Investment Management first reported a position in Cardiff Oncology in Q2 2014 and has held it in 11 quarters since.
BlackRock Investment Management's Cardiff Oncology position peaked at $877K in Q2 2015.
68 funds tracked by Wall St. Rank held Cardiff Oncology as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.